"For the newer GLP-1 medications, it would be useful to look at whether there are genetic variants, like the variants in PAM , that explain poor responders to their medications." "There are a whole class of medications that are insulin sensitizers, so perhaps we can develop medications that will allow people to be sensitized to GLP-1s or find formulations of GLP-1, like the longer-acting versions, that avoid the GLP-1 resistance." The research has been published in Genome Medicine .
Regulation of gastric emptying rate and its role in nutrient-induced GLP-1 secretion in rats after vertical sleeve gastrectomy
It smooths skin and prevents ageing
Microbial assimilatory sulfate reduction-mediated H2S production in the human gut
UTIs, presumably due to reduced immune cell function
For Ipamorelin, research protocols commonly reference doses in the range of 100-300mcg per administration, often administered one to three times daily depending on the research design